Electronic health records (EHRs) have providers and the public buzzing over their benefits, but pharmaceutical companies are excited, too—along with better safety surveillance and more efficient trial recruitment, this electronic information could trim the industry’s expenses. If companies gain access, that is. (Click here to continue reading)